ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CBAY Company Profile and Key Details

NASDAQ : CBAY

CymaBay Therapeutics, Inc.

$32.48

0.01+0.03%

Open: 4:00 PM

Not Actively Trading

63.02

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CBAY Stock Price Chart

Stock Price Today

CymaBay Therapeutics, Inc. (CBAY) stock surged +0.03%, trading at $32.48 on NASDAQ, up from the previous close of $32.47. The stock opened at $32.49, fluctuating between $32.48 and $32.50 in the recent session.

Stock Snapshot

32.47

Prev. Close

32.49

Open

3.73B

Market Cap

114.79M

Number of Shares

32.48

Day Low

32.5

Day High

-32.80808080808081

P/E Ratio

84.19%

Free Float in %

-0.99

EPS (TTM)

2.58

Book Value

-0.64

Cash Flow per Share

8.35M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 25, 2024	32.48	32.48	32.48	32.48	0
Mar 22, 2024	32.48	32.48	32.48	32.48	0
Mar 21, 2024	32.49	32.50	32.48	32.48	8.36M
Mar 20, 2024	32.49	32.49	32.47	32.47	1.52M
Mar 19, 2024	32.47	32.48	32.46	32.48	2.37M
Mar 18, 2024	32.46	32.48	32.45	32.46	3.47M
Mar 15, 2024	32.45	32.47	32.44	32.45	2.82M
Mar 14, 2024	32.44	32.47	32.42	32.47	2.69M
Mar 13, 2024	32.44	32.46	32.43	32.44	4.14M
Mar 12, 2024	32.43	32.46	32.43	32.44	3.66M
Mar 11, 2024	32.43	32.47	32.42	32.44	6.11M
Mar 08, 2024	32.30	32.33	32.28	32.31	1.77M
Mar 07, 2024	32.28	32.30	32.27	32.30	1.17M
Mar 06, 2024	32.25	32.30	32.25	32.29	1.4M
Mar 05, 2024	32.21	32.27	32.19	32.24	2.28M
Mar 04, 2024	32.24	32.30	32.16	32.18	2.15M
Mar 01, 2024	32.23	32.35	32.19	32.23	3.5M
Feb 29, 2024	32.28	32.30	32.17	32.19	7.91M
Feb 28, 2024	32.32	32.33	32.26	32.27	3.49M
Feb 27, 2024	32.26	32.33	32.24	32.32	2.84M

Contact Details

Newark, CA 94560

United States

Website: https://www.cymabay.comContact: 510 293 8800

About Company

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.

Frequently Asked Questions

What is the current CymaBay Therapeutics, Inc. (CBAY) stock price?

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) stock price is $32.48 in the last trading session. During the trading session, CBAY stock reached the peak price of $32.50 while $32.48 was the lowest point it dropped to. The percentage change in CBAY stock occurred in the recent session was 0.03% while the dollar amount for the price change in CBAY stock was $0.01.

CBAY's industry and sector of operation?

The NASDAQ listed CBAY is part of Biotechnology industry that operates in the broader Healthcare sector. CymaBay Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CBAY?

Mr. Ken Boehm
Senior Vice President of HR
Mr. Patrick J. O'Mara
Senior Vice President of Bus. Devel.
Dr. Robert L. Martin
Senior Vice President of Manufacturing & Nonclinical Devel.
Ms. Becki Filice
Senior Vice President of Portfolio & Product Leadership
Mr. Lewis J. Stuart B.A., BA, M.B.A., MBA
Chief Commercial Officer
Dr. Charles A. McWherter Ph.D.
Pres of R&D and Chief Scientific Officer
Dr. Dennis D. Kim M.B.A., M.D., MBA
Executive Officer
Mr. Daniel Menold
Vice President of Fin.
Mr. Sujal A. Shah
Pres, Chief Executive Officer & Director
Mr. Paul T. Quinlan
Gen. Counsel, Chief Compliance Officer & Corporation Sec.
Mr. Harish Shantharam C.F.A.
Chief Financial Officer

How CBAY did perform over past 52-week?

CBAY's closing price is 347.32% higher than its 52-week low of $7.26 where as its distance from 52-week high of $32.50 is -0.06%.

How many employees does CBAY have?

Number of CBAY employees currently stands at 101.

Link for CBAY official website?

Official Website of CBAY is: https://www.cymabay.com

How do I contact CBAY?

CBAY could be contacted at phone 510 293 8800 and can also be accessed through its website. CBAY operates from 7575 Gateway Boulevard, Newark, CA 94560, United States.

How many shares of CBAY are traded daily?

CBAY stock volume for the day was 8.35M shares. The average number of CBAY shares traded daily for last 3 months was 3.94M.

What is the market cap of CBAY currently?

The market value of CBAY currently stands at $3.73B with its latest stock price at $32.48 and 114.79M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

CBAY Stock Price Chart

Stock Price Today

Stock Snapshot

32.47

Prev. Close

32.49

Open

3.73B

Market Cap

114.79M

Number of Shares

32.48

Day Low

32.5

Day High

-32.80808080808081

P/E Ratio

84.19%

Free Float in %

-0.99

EPS (TTM)

2.58

Book Value

-0.64

Cash Flow per Share

8.35M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 25, 2024	32.48	32.48	32.48	32.48	0
Mar 22, 2024	32.48	32.48	32.48	32.48	0
Mar 21, 2024	32.49	32.50	32.48	32.48	8.36M
Mar 20, 2024	32.49	32.49	32.47	32.47	1.52M
Mar 19, 2024	32.47	32.48	32.46	32.48	2.37M
Mar 18, 2024	32.46	32.48	32.45	32.46	3.47M
Mar 15, 2024	32.45	32.47	32.44	32.45	2.82M
Mar 14, 2024	32.44	32.47	32.42	32.47	2.69M
Mar 13, 2024	32.44	32.46	32.43	32.44	4.14M
Mar 12, 2024	32.43	32.46	32.43	32.44	3.66M
Mar 11, 2024	32.43	32.47	32.42	32.44	6.11M
Mar 08, 2024	32.30	32.33	32.28	32.31	1.77M
Mar 07, 2024	32.28	32.30	32.27	32.30	1.17M
Mar 06, 2024	32.25	32.30	32.25	32.29	1.4M
Mar 05, 2024	32.21	32.27	32.19	32.24	2.28M
Mar 04, 2024	32.24	32.30	32.16	32.18	2.15M
Mar 01, 2024	32.23	32.35	32.19	32.23	3.5M
Feb 29, 2024	32.28	32.30	32.17	32.19	7.91M
Feb 28, 2024	32.32	32.33	32.26	32.27	3.49M
Feb 27, 2024	32.26	32.33	32.24	32.32	2.84M

Contact Details

Newark, CA 94560

United States

Website: https://www.cymabay.comContact: 510 293 8800

About Company

Frequently Asked Questions

What is the current CymaBay Therapeutics, Inc. (CBAY) stock price?

CBAY's industry and sector of operation?

Who are the executives of CBAY?

How CBAY did perform over past 52-week?

CBAY's closing price is 347.32% higher than its 52-week low of $7.26 where as its distance from 52-week high of $32.50 is -0.06%.

How many employees does CBAY have?

Number of CBAY employees currently stands at 101.

Link for CBAY official website?

Official Website of CBAY is: https://www.cymabay.com

How do I contact CBAY?

CBAY could be contacted at phone 510 293 8800 and can also be accessed through its website. CBAY operates from 7575 Gateway Boulevard, Newark, CA 94560, United States.

How many shares of CBAY are traded daily?

CBAY stock volume for the day was 8.35M shares. The average number of CBAY shares traded daily for last 3 months was 3.94M.

What is the market cap of CBAY currently?

The market value of CBAY currently stands at $3.73B with its latest stock price at $32.48 and 114.79M of its shares outstanding.

Employees	101
Beta	0.32
Sales or Revenue	$31.07M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	101
Beta	0.32
Sales or Revenue	$31.07M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CBAY Company Profile and Key Details

CymaBay Therapeutics, Inc.

CBAY Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

CBAY Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions